CDK2 and lung cancer: p57, a new member of the Kip/Cip family, is a broad‐acting CKI that is expressed in G1 and S phases of cells, inhibits DNA replication, and negatively regulates the cell cycle, its main substrate is CDK2, and it deletion or inactivation is common in human lung cancer cells.14